Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 26,500 | |||
5 mg | 在庫あり | ¥ 57,000 | |||
10 mg | 在庫あり | ¥ 91,500 | |||
25 mg | 在庫あり | ¥ 152,500 | |||
50 mg | 在庫あり | ¥ 217,000 | |||
100 mg | 在庫あり | ¥ 294,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 62,500 |
説明 | Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor. |
別名 | CM082, X-82 |
分子量 | 439.48 |
分子式 | C23H26FN5O3 |
CAS No. | 1013920-15-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22 mg/mL(50.06 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vorolanib 1013920-15-4 Angiogenesis Tyrosine Kinase/Adaptors PDGFR VEGFR Vascular endothelial growth factor receptor transporter angiogenesis ATP-binding tyrosine X82 ABC Inhibitor ABCG2 inhibit CM-082 Platelet-derived growth factor receptor TKI X 82 cassette CM 082 orally CM082 kinase HUVECs X-82 inhibitor